Merck sues government to avoid fine for cutting 340B drug sales program

Merck & Co. is suing the Biden administration to avoid potential fines for cutting off 340B contract pharmacies from getting discounted products, Fierce Healthcare reports. The pharmaceutical giant argues in a lawsuit filed July 8 in the U.S. District Court for the District of Columbia that favorable rulings in similar cases make a warning letter from the federal government moot.